亚盛医药-B(06855)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06855 亚盛医药-B

交易中 03-11 13:50:48

36.900

-0.500

-1.34%

最高37.550	最低36.550	成交量136.94万
今开36.750	昨收37.400	日振幅2.67%
总市值128.51亿	流通市值128.51亿	总股本3.48亿
成交额5,055万	换手率0.39%	流通股本3.48亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06855","market":"HK","secType":"STK","nameCN":"亚盛医药-B","latestPrice":36.9,"timestamp":1741672210496,"preClose":37.4,"halted":0,"volume":1369400,"delay":0,"floatShares":348266581,"shares":348266581,"eps":-3.513621642105263,"marketStatus":"交易中","change":-0.5,"latestTime":"03-11 13:50:48","open":36.75,"high":37.55,"low":36.55,"amount":50551956,"amplitude":0.026738,"askPrice":36.9,"askSize":8600,"bidPrice":36.85,"bidSize":4700,"shortable":3,"etf":0,"ttmEps":-1.3271751726315788,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1741680600000},"marketStatusCode":2,"adr":0,"listingDate":1572192000000,"exchange":"SEHK","adjPreClose":37.4,"openAndCloseTimeList":[[1741656600000,1741665600000],[1741669200000,1741680000000]],"volumeRatio":0.837752,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06855","defaultTab":"news","newsList":[{"id":"2518439812","title":"亚盛医药-B03月10日主力净流出126万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2518439812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518439812?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:17","pubTimestamp":1741594641,"startTime":"0","endTime":"0","summary":"03月10日, 亚盛医药-B股价跌3.73%，报收37.40元，成交金额1.01亿元，换手率0.76%，振幅6.18%，量比1.03。亚盛医药-B今日主力资金净流出126万元，上一交易日主力净流入951万元。该股近5个交易日上涨0.67%，主力资金累计净流入1932万元；近20日主力资金累计净流出548万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170845a269be6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170845a269be6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2517410562","title":"亚盛医药-B03月07日获主力加仓951万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517410562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517410562?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:15","pubTimestamp":1741335317,"startTime":"0","endTime":"0","summary":"03月07日, 亚盛医药-B股价涨0.91%，报收38.85元，成交金额1.65亿元，换手率1.20%，振幅7.66%，量比1.69。亚盛医药-B今日主力资金净流入951万元，连续4日净流入，上一交易日主力净流入139万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为72.73%，平均涨幅为2.22%。该股近5个交易日上涨3.06%，主力资金累计净流入1916万元；近20日主力资金累计净流出299万元，其中净流出天数为11日。该股主力净额占比0.07%，港股市场排名119/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307165827abecc42f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307165827abecc42f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"2517147943","title":"亚盛医药-B早盘涨超5% 耐立克®第三次获CDE纳入突破性治疗品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2517147943","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517147943?lang=zh_cn&edition=full","pubTime":"2025-03-07 10:47","pubTimestamp":1741315620,"startTime":"0","endTime":"0","summary":"　　亚盛医药-B早盘上涨5.07%，现报40.45港元，成交额7852.04万港元。　　亚盛医药-B发布公告，公司原创1类新药奥雷巴替尼获国家药品监督管理局药品审评中心纳入“突破性治疗品种”名单，用于联合化疗一线治疗新诊断费城染色体阳性（Ph+）急性淋巴细胞白血病患者。　　据悉，这是耐立克第三次获CDE纳入突破性治疗品种。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-07/doc-inenuuym7106212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","06855","BK4017","AAPG","BK4139","CDE","BK1574"],"gpt_icon":0},{"id":"2517903144","title":"港股异动 | 亚盛医药-B(06855)盘中涨超4% 耐立克®第三次获CDE纳入突破性治疗品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2517903144","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517903144?lang=zh_cn&edition=full","pubTime":"2025-03-07 10:21","pubTimestamp":1741314098,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，亚盛医药-B盘中涨超4%，截至发稿，涨4.55%，报40.25港元，成交额5269.94万港元。消息面上，亚盛医药-B发布公告，公司原创1类新药奥雷巴替尼获国家药品监督管理局药品审评中心纳入“突破性治疗品种”名单，用于联合化疗一线治疗新诊断费城染色体阳性(Ph+)急性淋巴细胞白血病患者。据悉，这是耐立克第三次获CDE纳入突破性治疗品种。耐立克是亚盛医药原创1类新药，为中国首个获批上市的第三代BCR-ABL抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AAPG","CDE","06855","BK1161","BK4139","BK1574","BK4017"],"gpt_icon":0},{"id":"2517514496","title":"亚盛医药-B盘中异动 早盘大幅拉升5.06%报40.450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517514496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517514496?lang=zh_cn&edition=full","pubTime":"2025-03-07 10:16","pubTimestamp":1741313815,"startTime":"0","endTime":"0","summary":"2025年03月07日早盘10时16分，亚盛医药-B股票出现波动，股价快速拉升5.06%。截至发稿，该股报40.450港元/股，成交量123.87万股，换手率0.36%，振幅7.14%。资金方面，该股资金流入2297.16万港元，流出1346.61万港元。亚盛医药-B股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，百奥赛图-B、云顶新耀-B、腾盛博药-B涨幅较大，振幅较大的相关个股有创胜集团-B、百奥赛图-B、云顶新耀-B，振幅分别为18.09%、12.64%、11.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307101655a26347a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307101655a26347a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06855"],"gpt_icon":0},{"id":"2517908543","title":"耐立克®治疗费城染色体阳性（Ph+）急性淋巴细胞白血病（ALL）获突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908543","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517908543?lang=zh_cn&edition=full","pubTime":"2025-03-06 09:42","pubTimestamp":1741225320,"startTime":"0","endTime":"0","summary":"美国马里兰州罗克维尔市和中国苏州2025年3月6日 /美通社/ -- 致力于在血液肿瘤等领域开发创新药物的领先的生物医药企业——亚盛医药今日宣布，公司原创1类新药奥雷巴替尼获国家药品监督管理局药品审评中心纳入\"突破性治疗品种\"名单，用于联合化疗一线治疗新诊断费城染色体阳性（Ph+）急性淋巴细胞白血病患者。此次耐立克获纳入突破性治疗品种，显示了该药物在Ph+ ALL这一预后恶劣的血液肿瘤治疗领域具重大临床潜力和价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4634781_ZH34781_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4107","LU1699723380.USD","BK4533","BK4585","06855","AAPG","LU1571399168.USD","BK4139","BK4588","BK1161","LU0985320562.USD","BK1574","LU2355687059.USD","ALL"],"gpt_icon":0},{"id":"2517997516","title":"亚盛医药-B(06855)：耐立克®治疗费城染色体阳性(Ph+)急性淋巴细胞白血病获突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2517997516","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517997516?lang=zh_cn&edition=full","pubTime":"2025-03-06 07:55","pubTimestamp":1741218920,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚盛医药-B 发布公告，公司原创1类新药奥雷巴替尼获国家药品监督管理局药品审评中心纳入“突破性治疗品种”名单，用于联合化疗一线治疗新诊断费城染色体阳性(Ph+)急性淋巴细胞白血病患者。这是耐立克第三次获CDE纳入突破性治疗品种。2023年7月，耐立克获CDE临床试验许可，开展其联合化疗对比伊马替尼联合化疗治疗新诊断Ph+ ALL患者的全球注册III期临床研究，意味着该药物有望成为国内首个获批用于一线治疗Ph+ ALL的TKI药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258313.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"亚盛医药-B(06855)：耐立克®治疗费城染色体阳性(Ph+)急性淋巴细胞白血病获突破性疗法认定","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","BK4139","BK1574","AAPG","06855"],"gpt_icon":0},{"id":"2517599545","title":"亚盛医药-B03月05日获主力加仓549万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517599545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517599545?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:17","pubTimestamp":1741162632,"startTime":"0","endTime":"0","summary":"03月05日, 亚盛医药-B股价涨1.86%，报收38.35元，成交金额6999万元，换手率0.53%，振幅3.98%，量比0.51。亚盛医药-B今日主力资金净流入549万元，上一交易日主力净流入417万元。该股近5个交易日下跌4.46%，主力资金累计净流入206万元；近20日主力资金累计净流出61万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170809a2605de8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170809a2605de8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1574","BK1161"],"gpt_icon":0},{"id":"2516625272","title":"亚盛医药-B03月04日主力净流入417万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2516625272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516625272?lang=zh_cn&edition=full","pubTime":"2025-03-04 17:38","pubTimestamp":1741081129,"startTime":"0","endTime":"0","summary":"03月04日, 亚盛医药-B股价涨1.07%，报收37.65元，成交金额7239万元，换手率0.56%，振幅5.37%，量比0.48。亚盛医药-B今日主力资金净流入417万元，上一交易日主力净流出141万元。该股近5个交易日下跌5.28%，主力资金累计净流出1212万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出607万元，其中净流出天数为12日。该股主力净额占比0.03%，港股市场排名140/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174454abe79351&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174454abe79351&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06855"],"gpt_icon":0},{"id":"2514397724","title":"亚盛医药-B盘中异动 下午盘股价大跌5.04%报37.650港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514397724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514397724?lang=zh_cn&edition=full","pubTime":"2025-02-28 14:34","pubTimestamp":1740724446,"startTime":"0","endTime":"0","summary":"2025年02月28日下午盘14时34分，亚盛医药-B股票出现波动，股价大幅跳水5.04%。截至发稿，该股报37.650港元/股，成交量265.6万股，换手率0.76%，振幅5.93%。资金方面，该股资金流入3457.89万港元，流出4717.33万港元。亚盛医药-B股票所在的生物技术行业中，整体跌幅为0.72%。而另一方面，亚盛医药此次IPO不仅是2025年美股生物医药第一股，也是首例通过中国证监会备案的港股上市公司赴美双重主要上市企业，更是全球生物医药IPO第一股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228143407a2576998&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228143407a2576998&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2514497938","title":"亚盛医药-B盘中异动 下午盘股价大跌5.08%报38.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514497938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514497938?lang=zh_cn&edition=full","pubTime":"2025-02-27 13:32","pubTimestamp":1740634343,"startTime":"0","endTime":"0","summary":"2025年02月27日下午盘13时32分，亚盛医药-B股票出现异动，股价大幅下挫5.08%。截至发稿，该股报38.300港元/股，成交量332.69万股，换手率0.96%，振幅6.32%。资金方面，该股资金流入4456.05万港元，流出5763.14万港元。亚盛医药-B股票所在的生物技术行业中，整体跌幅为1.78%。而另一方面，亚盛医药此次IPO不仅是2025年美股生物医药第一股，也是首例通过中国证监会备案的港股上市公司赴美双重主要上市企业，更是全球生物医药IPO第一股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022713322496321328&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022713322496321328&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06855"],"gpt_icon":0},{"id":"2514886196","title":"亚盛医药-B02月26日遭主力抛售869万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514886196?lang=zh_cn&edition=full","pubTime":"2025-02-26 16:16","pubTimestamp":1740557776,"startTime":"0","endTime":"0","summary":"02月26日, 亚盛医药-B股价涨1.51%，报收40.35元，成交金额2.18亿元，换手率1.56%，振幅4.53%，量比1.18。亚盛医药-B今日主力资金净流出869万元，连续3日净流出，上一交易日主力净流出422万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为58.33%，平均跌幅为2.64%。该股近5个交易日上涨6.74%，主力资金累计净流出1482万元；近20日主力资金累计净流入1.36亿元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226164936abdd93c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226164936abdd93c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06855","BK1574"],"gpt_icon":0},{"id":"2514241094","title":"亚盛医药-B(06855)：陈焯墁已获委任为公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2514241094","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514241094?lang=zh_cn&edition=full","pubTime":"2025-02-25 21:58","pubTimestamp":1740491889,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚盛医药-B(06855)发布公告，王章旗已辞任(i)公司秘书;(ii)香港联合交易所有限公司证券上市规则第3.05条规定的授权代表;及(iii)香港法例第622章公司条例第16部下获授权代表公司接收法律程序文件及通知书的人士及上市规则第19.05(2)条下代表公司接受法律程序文件及通知书的授权代表，均自2025年2月25日起生效。随王先生辞任后，陈焯墁已获委任为公司秘书、3.05条授权代表及公司条例及19.05条授权代表，均自2025年2月25日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254313.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AAPG","BK1574","BK1161","BK4139","06855"],"gpt_icon":0},{"id":"2513869794","title":"亚盛医药-B盘中异动 急速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513869794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513869794?lang=zh_cn&edition=full","pubTime":"2025-02-24 11:32","pubTimestamp":1740367961,"startTime":"0","endTime":"0","summary":"2025年02月24日临近午盘11时32分，亚盛医药-B股票出现异动，股价急速跳水5.07%。截至发稿，该股报39.350港元/股，成交量341.077万股，换手率0.98%，振幅7.48%。亚盛医药-B股票所在的生物技术行业中，整体跌幅为2.12%。亚盛医药-B公司简介：亚盛医药集团是一家主要从事血液系统恶性肿瘤治疗药物发现、研发及商业化的控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224113242962df07c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224113242962df07c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06855"],"gpt_icon":0},{"id":"2512541306","title":"亚盛医药-B02月20日遭主力抛售491万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512541306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512541306?lang=zh_cn&edition=full","pubTime":"2025-02-20 16:15","pubTimestamp":1740039343,"startTime":"0","endTime":"0","summary":"02月20日, 亚盛医药-B股价涨0.79%，报收38.15元，成交金额1.45亿元，换手率1.08%，振幅4.76%，量比1.01。亚盛医药-B今日主力资金净流出491万元，上一交易日主力净流出40万元。该股近5个交易日上涨13.27%，主力资金累计净流入626万元；近20日主力资金累计净流入2.44亿元，其中净流入天数为13日。该股主力净额占比0.04%，港股市场排名2481/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220161612abd5de39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220161612abd5de39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06855","BK1574"],"gpt_icon":0},{"id":"2512111961","title":"中国内地投资者周二港股通净买入额创四年来最高","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111961","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512111961?lang=zh_cn&edition=full","pubTime":"2025-02-19 07:37","pubTimestamp":1739921873,"startTime":"0","endTime":"0","summary":"中国内地投资者周二通过港股通净买入224亿港元的香港股票，继续推动DeepSeek引发的科技股涨势。彭博数据显示，这是自2021年初以来最大单日净买入，也是有纪录以来第四高。恒生科技指数当日大涨2.5%，有望连续第六周上涨。内地资金大量涌入香港股市，已推动A股市场相较港股的溢价幅度缩小至约34%，这使得一项A-H股溢价指数接近在过去总会触发反弹的底部，引发了香港上市中资股跑赢内地股票的幅度可能缩小的担忧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01921","06699","BK1133","03360","02533","02688","00300","02157","09987","00826","00008","00548","00384","00152","01024","00939","09969","02618","03969","03618","01952","00267","00220","03988","01199","06160","06680","00142","00270","SG9999002463.SGD","00005","01691","02208","01347","00412","03690","01052","02005","01357","01772","02607","02015","00257","02016","09626","09992","00003","01860","00981","09922","01579","02268","00175","00728","02096","00316","00013","02018","02282","02057","03650","00189","01810","00303","03328","00038","02333","02338","01310","02121","00107","03692","00148","00327","00853","01128","01193","01907","09696","00425","01530","06618","02600","00392","00512","00777","06821","09885","00467","01211","02367","06990","00751","02155","06855","01071","06818","03888","09899","00762","00788","01138","02162","02382","02386","01888","01675","09995","01405","00546","01787","06127","02883","03933","01519","02291","03396","01876","01789","01963","09926","00241","03369","06181","00144","01818","01513","HSCEI","01177","01735","09868","02269","09858","BK1536","00772","01855","00371","00576","01341","BK1589","02400","06198","01070","01112","01658","00819","00666","01766","02402","02359","00855","01929","00868","00836","03311","00177","06186","00659","02465","00006","02380","01618","06060","00014","01119","02601","09988","00288","01686","HSTECH","03968","02498","BK1506","00861","06069","02099","02158","00991","06690","01066","00856","01093","00590","01541","01585","00867","02105","09923","06936","02171","06616","02172","01558","09688","09880","09890","00293","06808","01919","02186","00317","06110","03800","03918","03606"],"gpt_icon":0},{"id":"2512351751","title":"亚盛医药-B02月18日获主力加仓603万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512351751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512351751?lang=zh_cn&edition=full","pubTime":"2025-02-18 16:15","pubTimestamp":1739866517,"startTime":"0","endTime":"0","summary":"02月18日, 亚盛医药-B股价涨3.62%，报收37.20元，成交金额1.61亿元，换手率1.25%，振幅5.01%，量比1.37。亚盛医药-B今日主力资金净流入603万元，连续3日净流入，上一交易日主力净流入31万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为46.67%，平均涨幅为4.17%。该股近5个交易日上涨3.33%，主力资金累计净流出122万元；近20日主力资金累计净流入2.68亿元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218161531a24a45ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218161531a24a45ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2511686327","title":"亚盛医药(06855.HK)行使美国存托股份超额配股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2511686327","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511686327?lang=zh_cn&edition=full","pubTime":"2025-02-14 09:57","pubTimestamp":1739498220,"startTime":"0","endTime":"0","summary":"亚盛医药公布，包销商已行使超额配股权及有关超额配股权之交割已于美国东部时间昨日进行，公司按照发售价为每股美国存托股份17.25美元发行93.51万股美国存托股份，紧随有关超额配股权交割后约占已发行普通股的1.07%。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20201214152342289_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20201214152342289_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1417288/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2511501242","title":"【亚盛医药-B(06855.HK)：行使有关发售美国存托股份的部分超额配股权的交割】亚盛医药-B(06855.HK)发布公告，包销商已行使超额配股权及有关超额配股权的交割已于2025年2月13日(美国东部时间)进行。公司按照发售价为每股美国存托股份17.25美元发行935,144股美国存托股份(根据代表比率，相当于374.06万股相关股份)(可选美国存托股份)，紧随有关超额配股权交割后约占已发行普通股的1.07%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511501242","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511501242?lang=zh_cn&edition=full","pubTime":"2025-02-14 07:37","pubTimestamp":1739489842,"startTime":"0","endTime":"0","summary":"亚盛医药-B(06855.HK)发布公告，包销商已行使超额配股权及有关超额配股权的交割已于2025年2月13日(美国东部时间)进行。公司按照发售价为每股美国存托股份17.25美元发行935,144股美国存托股份(根据代表比率，相当于374.06万股相关股份)(可选美国存托股份)，紧随有关超额配股权交割后约占已发行普通股的1.07%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14073748151376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","06855","BK1161","BK4139","AAPG"],"gpt_icon":0},{"id":"2511501961","title":"亚盛医药-B(06855)：行使有关发售美国存托股份的部分超额配股权的交割","url":"https://stock-news.laohu8.com/highlight/detail?id=2511501961","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511501961?lang=zh_cn&edition=full","pubTime":"2025-02-14 07:30","pubTimestamp":1739489439,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚盛医药-B(06855)发布公告，包销商已行使超额配股权及有关超额配股权的交割已于2025年2月13日(美国东部时间)进行。公司按照发售价为每股美国存托股份17.25美元发行935,144股美国存托股份(根据代表比率，相当于374.06万股相关股份)(可选美国存托股份)，紧随有关超额配股权交割后约占已发行普通股的1.07%。有关发售项下可选美国存托股份的所得款项总额约为1613万美元。有关发售项下可选美国存托股份的所得款项净额约为110万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AAPG","BK1574","BK1161","BK4139","06855"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascentagepharma.com","stockEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0081},{"period":"3month","weight":-0.101},{"period":"6month","weight":0.1402},{"period":"1year","weight":0.5649},{"period":"ytd","weight":-0.1771}],"compareEarnings":[{"period":"1week","weight":0.0338},{"period":"1month","weight":0.1254},{"period":"3month","weight":0.1709},{"period":"6month","weight":0.3901},{"period":"1year","weight":0.4543},{"period":"ytd","weight":0.1856}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Ascentage Pharma Group International是一家主要从事血液系统恶性肿瘤治疗药物的发现、研发及商业化的控股公司。该公司主营业务是从事开发及销售针对癌症、乙肝病毒及某些与年龄相关的疾病的新型小规模疗法。该公司的主要产品包括Olverembatinib（HQP1351）、Lisaftoclax（APG-2575）、Alrizomadlin（APG-115）、Pelcitoclax（APG-1252）、APG-5918等产品。该公司的产品主要用于治疗主要血液系统恶性肿瘤，包括慢性粒细胞白血病、急性粒细胞白血病、慢性淋巴细胞白血病、急性淋巴细胞白血病、骨髓增生异常综合征及多发性骨髓瘤。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.093585},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.035469},{"month":3,"riseRate":0,"avgChangeRate":-0.127511},{"month":4,"riseRate":0.8,"avgChangeRate":0.111517},{"month":5,"riseRate":0.4,"avgChangeRate":0.061168},{"month":6,"riseRate":0.8,"avgChangeRate":0.262196},{"month":7,"riseRate":0.4,"avgChangeRate":-0.080666},{"month":8,"riseRate":0.8,"avgChangeRate":0.030238},{"month":9,"riseRate":0.2,"avgChangeRate":-0.085141},{"month":10,"riseRate":0.6,"avgChangeRate":0.075164},{"month":11,"riseRate":0.5,"avgChangeRate":0.0779},{"month":12,"riseRate":0.666667,"avgChangeRate":0.084992}],"exchange":"SEHK","name":"亚盛医药-B","nameEN":"ASCENTAGE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.5","shortVersion":"4.31.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亚盛医药-B(06855)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亚盛医药-B(06855)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亚盛医药-B,06855,亚盛医药-B股票,亚盛医药-B股票老虎,亚盛医药-B股票老虎国际,亚盛医药-B行情,亚盛医药-B股票行情,亚盛医药-B股价,亚盛医药-B股市,亚盛医药-B股票价格,亚盛医药-B股票交易,亚盛医药-B股票购买,亚盛医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亚盛医药-B(06855)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亚盛医药-B(06855)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}